Fractalkine Depresses Cardiomyocyte Contractility

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Taube, David ^a   Xu, Jiang ^a   Yang, Xiao Ping ^a   Undrovinas, Albertas ^a   Peterson, Edward ^a   Harding, Pamela ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRACTALKINE; FURA 2 ACETOXYMETHYL ESTER; ISOPRENALINE; PROSTAGLANDIN E2; TROPONIN I;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; C57BL 6 MOUSE; CALCIUM CELL LEVEL; CELL CULTURE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE RELEASE; ELECTRIC FIELD; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; HEART LEFT VENTRICLE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART STIMULATION; KNOCKOUT MOUSE; MALE; MOUSE; NEWBORN; NONHUMAN; PROTEIN PHOSPHORYLATION; WILD TYPE;

ANIMALS; CALCIUM; CARDIOTONIC AGENTS; CHEMOKINE CX3CL1; DINOPROSTONE; GENE EXPRESSION; HEART VENTRICLES; ISOPROTERENOL; MALE; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; PHOSPHORYLATION; RECEPTORS, CHEMOKINE; RECEPTORS, PROSTAGLANDIN E, EP4 SUBTYPE; TROPONIN I;

EID: 84880790022     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069832     Document Type: Article

References (35)

1. Comerford I, McColl SR, (2011) Mini-review series: focus on chemokines. Immunol Cell Biol 89: 183-184.
2. Sozzani S, Bonecchi R, D'Amico G, Luini W, Bernasconi S, et al. (1998) Old and new chemokines. Pharmacological regulation of chemokine production and receptor expression: mini-review. J Chemother 10: 142-145.
3. Ludwig A, Weber C, (2007) Transmembrane chemokines: versatile 'special agents' in vascular inflammation. Thromb Haemost 97: 694-703.
4. Xuan W, Liao Y, Chen B, Huang Q, Xu D, et al. (2011) Detrimental effect of fractalkine on myocardial ischaemia and heart failure. Cardiovasc Res 92: 385-393.
5. Yoshida T, Hanawa H, Toba K, Watanabe H, Watanabe R, et al. (2005) Expression of immunological molecules by cardiomyocytes and inflammatory and interstitial cells in rat autoimmune myocarditis. Cardiovasc Res 68: 278-288.
6. Husberg C, Nygard S, Finsen AV, Damas JK, Frigessi A, et al. (2008) Cytokine expression profiling of the myocardium reveals a role for CX3CL1 (fractalkine) in heart failure. J Mol Cell Cardiol 45: 261-269.
7. Richter B, Koller L, Hohensinner PJ, Rychli K, Zorn G, et al. (2012) Fractalkine is an independent predictor of mortality in patients with advanced heart failure. Thromb Haemost 108: 1220-1227.
8. Haskell CA, Hancock WW, Salant DJ, Gao W, Csizmadia V, et al. (2001) Targeted deletion of CX(3)CR1 reveals a role for fractalkine in cardiac allograft rejection. J Clin Invest 108: 679-688.
9. Date T, Yamashita T, Sekiguchi A, Iwasaki YK, Aizawa T, et al. (2009) Infiltration of macrophages through the atrial endocardium of inflammation-induced rats: contribution of fractalkine. Circ J 73: 932-937.
10. Ishida Y, Gao JL, Murphy PM, (2008) Chemokine receptor CX3CR1 mediates skin wound healing by promoting macrophage and fibroblast accumulation and function. J Immunol 180: 569-579.
11. Sung MJ, Kim DH, Davaatseren M, Hur HJ, Kim W, et al. (2010) Genistein suppression of TNF-alpha-induced fractalkine expression in endothelial cells. Cell Physiol Biochem 26: 431-440.
12. Matsumoto Y, Tsukada Y, Miyakoshi A, Sakuma H, Kohyama K, (2004) C protein-induced myocarditis and subsequent dilated cardiomyopathy: rescue from death and prevention of dilated cardiomyopathy by chemokine receptor DNA therapy. J Immunol 173: 3535-3541.
13. Kaikita K, Hayasaki T, Okuma T, Kuziel WA, Ogawa H, et al. (2004) Targeted deletion of CC chemokine receptor 2 attenuates left ventricular remodeling after experimental myocardial infarction. Am J Pathol 165: 439-447.
14. Harding P, Yang XP, Yang J, Shesely E, He Q, et al. (2010) Gene expression profiling of dilated cardiomyopathy in older male EP4 knockout mice. Am J Physiol Heart Circ Physiol 298: H623-H632.
15. Harding P, Carretero OA, LaPointe MC, (1995) Effects of interleukin-1 beta and nitric oxide on cardiac myocytes. Hypertension 25: 421-430.
16. Winer J, Jung CK, Shackel I, Williams PM, (1999) Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem 270: 41-49.
17. O'Connell TD, Rodrigo MC, Simpson PC, (2007) Isolation and culture of adult mouse cardiac myocytes. Methods Mol Biol 357: 271-296.
18. Pyo RT, Sui J, Dhume A, Palomeque J, Blaxall BC, et al. (2006) CXCR4 modulates contractility in adult cardiac myocytes. J Mol Cell Cardiol 41: 834-844.
19. Holzinger C, Schollhammer A, Imhof M, Reinwald C, Kramer G, et al. (1995) Phenotypic patterns of mononuclear cells in dilated cardiomyopathy. Circulation 92: 2876-2885.
20. Shan J, Kushnir A, Betzenhauser MJ, Reiken S, Li J, et al. (2010) Phosphorylation of the ryanodine receptor mediates the cardiac fight or flight response in mice. J Clin Invest 120: 4388-4398.
21. Park J, Song KH, Ha H, (2012) Fractalkine increases mesangial cell proliferation through reactive oxygen species and mitogen-activated protein kinases. Transplant Proc 44: 1026-1028.
22. Harding P, Yang XP, He Q, LaPointe MC, (2011) Lack of microsomal prostaglandin E synthase-1 reduces cardiac function following angiotensin II infusion. Am J Physiol Heart Circ Physiol 300: H1053-H1061.
23. Layland J, Solaro RJ, Shah AM, (2005) Regulation of cardiac contractile function by troponin I phosphorylation. Cardiovasc Res 66: 12-21.
24. Zhang P, Kirk JA, Ji W, Dos Remedios CG, Kass DA, et al. (2012) Multiple Reaction Monitoring to Identify Site-Specific Troponin I Phosphorylated Residues in the Failing Human Heart. Circulation 126(15): 1828-37.
25. Zhang J, Guy MJ, Norman HS, Chen YC, Xu Q, et al. (2011) Top-down quantitative proteomics identified phosphorylation of cardiac troponin I as a candidate biomarker for chronic heart failure. J Proteome Res 10: 4054-4065.
26. Cawley SM, Kolodziej S, Ichinose F, Brouckaert P, Buys ES, et al. (2011) sGC{alpha}1 mediates the negative inotropic effects of NO in cardiac myocytes independent of changes in calcium handling. Am J Physiol Heart Circ Physiol 301: H157-H163.
27. LaRocca TJ, Schwarzkopf M, Altman P, Zhang S, Gupta A, et al. (2010) beta2-Adrenergic receptor signaling in the cardiac myocyte is modulated by interactions with CXCR4. J Cardiovasc Pharmacol 56: 548-559.
28. Escher F, Vetter R, Kuhl U, Westermann D, Schultheiss HP, et al. (2011) Fractalkine in human inflammatory cardiomyopathy. Heart 97: 733-739.
29. Tang EH, Shimizu K, Christen T, Rocha VZ, Shvartz E, et al. (2011) Lack of EP4 receptors on bone marrow-derived cells enhances inflammation in atherosclerotic lesions. Cardiovasc Res 89: 234-243.
30. Shi J, Johansson J, Woodling NS, Wang Q, Montine TJ, et al. (2010) The prostaglandin E2 E-prostanoid 4 receptor exerts anti-inflammatory effects in brain innate immunity. J Immunol 184: 7207-7218.
31. Minami M, Shimizu K, Okamoto Y, Folco E, Ilasaca ML, et al. (2008) Prostaglandin E receptor type 4-associated protein interacts directly with NF-kappaB1 and attenuates macrophage activation. J Biol Chem 283: 9692-9703.
32. Zahner G, Schaper M, Panzer U, Kluger M, Stahl RA, et al. (2009) Prostaglandin EP2 and EP4 receptors modulate expression of the chemokine CCL2 (MCP-1) in response to LPS-induced renal glomerular inflammation. Biochem J 422: 563-570.
33. Suzuki J, Ogawa M, Futamatsu H, Kosuge H, Tanaka H, et al. (2006) Cyclooxygenase-2 inhibitor alters Th1/Th2 cytokine balance and suppresses autoimmune myocarditis in rats. J Mol Cell Cardiol 40: 688-695.
34. Ogawa M, Suzuki J, Kosuge H, Takayama K, Nagai R, et al. (2009) The mechanism of anti-inflammatory effects of prostaglandin E2 receptor 4 activation in murine cardiac transplantation. Transplantation 87: 1645-1653.
35. Ricciotti E, FitzGerald GA, (2011) Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol 31: 986-1000.